TRMS paydirt =)
AP
Trimeris HIV Drug Sales Grow 16 Percent
Tuesday April 17, 4:47 pm ET
Trimeris Sales Increase 16 Percent for HIV Drug Fuzeon Driven by Growth Outside the U.S.
MORRISVILLE, N.C. (AP) -- Biopharmaceutical company Trimeris Inc. said sales of its HIV drug Fuzeon increased 16 percent in the first quarter, driven by growth outside the U.S.
First-quarter net sales of the drug grew to $64.3 million, from $55.4 million a year ago.
Sales outside the U.S. and Canada jumped 25 percent to $35 million, from $28 million in the prior year.
Fuzeon's sales within the U.S and Canada increased 7 percent to $29.3 million, from $27.4 million a year ago.
Acting President and Chief Operating Officer E. Lawrence Hill said North American sales of Fuzeon decreased from the fourth quarter, due to wholesaler stocking during the first quarter. He said inventory levels at U.S. wholesalers returned to normal levels during the first quarter.
Trimeris shares jumped 21 cents, or 3.2 percent, to close at $6.74 on the Nasdaq Stock Market. The stock, which reached a 52-week high of $13.85 in February has since fallen, most recently in mid-March on news that its chief executive and chief financial officer retired
